Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Dean J. Kereiakes

October 12, 2015

REGISTER for free or LOG IN to view this content

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presentation

TCT 2015

Up Next

Presentation TCT 2015

Should Every Referral for CABG Be Proceeded by Physiological Assessment?

Presenter: Erick Schampaert

October 12, 2015

More slides +

Presentation TCT 2015

Severe Frailty With Aortic Stenosis and TAVR: Case Presentation

Presenter: Sandra Lauck

October 12, 2015

Presentation TCT 2015

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective

Presenter: Robert A. Harrington

October 12, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.